POEMS syndrome: A clue to understanding primary pulmonary hypertension? A review of current insights into the pathogenesis of primary pulmonary hypertension

Canadian Journal of Cardiology

Volumn 16, Issue 8, 2000, Pages 975-981

  Helmersen, D S ^a   Ford, G T ^a   Viner, S M ^a   Auger, W R ^a  

^a Rockyview General Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE; PROSTACYCLIN; SEROTONIN; THROMBOXANE A2;

DISEASE CLASSIFICATION; EDITORIAL; GENETIC ASSOCIATION; HUMAN; INFLAMMATION; NONHUMAN; PARAPROTEINEMIA; PATHOGENESIS; PULMONARY HYPERTENSION; VASCULAR RESISTANCE; VASOCONSTRICTION;

HUMAN; HYPERTENSION, PULMONARY; LUNG; POEMS SYNDROME; VASCULAR RESISTANCE;

EID: 0033825415     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (53)

1. Pulmonary hypertension
2. ACCP Consensus statement: Primary pulmonary hypertension
3. Primary pulmonary hypertension. A national prospective study
4. Coexistent pulmonary and portal hypertension: Morphological and clinical features
5. Pulmonary hypertension in patients with HIV infection: Comparison with primary pulmonary hypertension
6. Pulmonary hypertension associated with long term inhalation of 'crack' methamphetamine
7. Appetite suppressant drugs and the risk of primary pulmonary hypertension
8. Primary pulmonary hypertension. Insights into the pathogenesis from epidemiology
9. Primary pulmonary hypertension
10. Pulmonary hypertension in POEMS syndrome. A new feature mediated by cytokines
11. Survival in patients with primary pulmonary hypertension
12. Primary pulmonary hypertension: Length of survival in patients referred for heart-lung transplantation
13. A survey of diagnostic practices and the use of epoprostenol in patients with PPH
14. The pathology of PPH
15. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension
16. Specificity of pulmonary vascular lesions in primary pulmonary hypertension
17. An epidemic of pulmonary hypertension after toxic rapeseed oil ingestion in Spain
18. Primary pulmonary hypertension in HIV infection
19. Histopathology of pulmonary hypertension: A quantitative and qualitative study of 58 patients
20. Experimental extreme pulmonary hypertension and vascular disease in relation to polycythemia
21. Primary pulmonary hypertension: A histopathologic study of 80 cases
22. Pulmonary hypertension and cor pulmonale
23. The pathogenesis of atherosclerosis: A perspective for the 1990s
24. Pathophysiology of primary pulmonary hypertension: From physiology to molecular mechanisms
25. Significance of high plasma serotonin in primary pulmonary hypertension
26. Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat
27. Paradoxical constriction to platelets by arteries from rats with pulmonary hypertension
28. An imbalance between excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension
29. Endothelium-derived hyperpolarizing factor - Fact or fiction?
30. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of endothelium derived relaxing factors
31. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
32. Prostacyclin-induced acute pulmonary vasodilatation in primary pulmonary hypertension
33. Reduction in pulmonary vascular resistance with long-term prostacyclin therapy in primary pulmonary hypertension
34. Neurohumeral activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamics and endothelin levels
35. Expression of endothelin-1 in the lungs of patients with primary pulmonary hypertension
36. Observations on the pulmonary arterial blood pressure in the cat
37. Effects of hypoxia and other vasoactive agents on the pulmonary and cerebral artery smooth muscle cells
38. + channels in pulmonary artery smooth muscle cells
39. The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension
40. Inflammatory mediator effects of pulmonary blood flow, edema and vascular endothelium
41. Regulation of vascular tone
42. Lung mast cells in plexogenic pulmonary arteriopathy
43. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
44. Plexiform pulmonary vascular lesions in scleroderma and AIDS: Is there a common pathogenesis?
45. Genetics and immunogenetic aspects of primary pulmonary hypertension
46. Increased IL-1 and IL-6 serum concentrations in severe primary pulmonary hypertension
47. Overproduction of proinflammatory cytokines balanced by their antagonists in POEMS syndrome
48. Growth factors in POEMS syndrome: Evidence for marked increase in circulating vascular endothelial growth factor
49. Pulmonary hypertension associated with the use of fenfluramine derivatives
50. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension
51. Acute hemodynamic effects of subcutaneous UT-15 in primary pulmonary hypertension
52. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension
53. Inhaled nitric oxide used as a bridge to heart lung transplantation in a patient with end stage pulmonary hypertension